SPL VIRALEZE COVID-19 nasal spray to be ready for market Q1CY21 10/12/20 PRICE SENSITIVE download Created with Sketch. 112.23KB Share SPL AGM Chairman address and CEO presentation 20/11/20 PRICE SENSITIVE download Created with Sketch. 3.8MB Share SPL SPL7013 shows potent antiviral activity in RSV 19/11/20 PRICE SENSITIVE download Created with Sketch. 94.96KB Share SPL Quarterly Cashflow and Activities Report 30/10/20 PRICE SENSITIVE download Created with Sketch. 184.83KB Share SPL Completion of Placement and SPP raises $48.9M in total 29/10/20 PRICE SENSITIVE download Created with Sketch. 50.98KB Share SPL Starpharma receives $5.7M R&D tax incentive refund 21/10/20 PRICE SENSITIVE download Created with Sketch. 51.17KB Share SPL Share Purchase Plan offer document 07/10/20 PRICE SENSITIVE download Created with Sketch. 398.73KB Share SPL Starpharma completes oversubscribed A$45M placement 30/09/20 PRICE SENSITIVE download Created with Sketch. 66.2KB Share SPL Trading Halt 28/09/20 PRICE SENSITIVE download Created with Sketch. 146.29KB Share SPL SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2 14/09/20 PRICE SENSITIVE download Created with Sketch. 182.76KB Share SPL Starpharma awarded $1M MRFF funding for COVID-19 spray 03/09/20 PRICE SENSITIVE download Created with Sketch. 93.54KB Share SPL SPL creates slow release soluble DEP remdesivir nanoparticle 01/09/20 PRICE SENSITIVE download Created with Sketch. 89.37KB Share SPL Starpharma annual report and full year financial results 27/08/20 PRICE SENSITIVE download Created with Sketch. 5.82MB Share SPL SPL7013 nasal spray for COVID19 development update 25/08/20 PRICE SENSITIVE download Created with Sketch. 266.09KB Share SPL Starpharma signs new DEP partnership with Chase Sun 17/08/20 PRICE SENSITIVE download Created with Sketch. 57.35KB Share SPL Quarterly Cashflow and Activities Report 30/07/20 PRICE SENSITIVE download Created with Sketch. 218.5KB Share SPL DEP irinotecan boosts immuno-oncology in colon cancer models 29/06/20 PRICE SENSITIVE download Created with Sketch. 111.67KB Share SPL DEP products showcased at AACR 2020 23/06/20 PRICE SENSITIVE download Created with Sketch. 67.38KB Share SPL DEP lutetium effective in human prostate cancer model 17/06/20 PRICE SENSITIVE download Created with Sketch. 108.55KB Share SPL VivaGel BV launched in central and eastern Europe 16/06/20 PRICE SENSITIVE download Created with Sketch. 56.59KB Share SPL DEP irinotecan phase 2 commences after positive phase 1 07/05/20 PRICE SENSITIVE download Created with Sketch. 108.92KB Share SPL SPL7013 shows significant activity against coronavirus 15/04/20 PRICE SENSITIVE download Created with Sketch. 68.84KB Share SPL Quarterly Cashflow and Activity Report 07/04/20 PRICE SENSITIVE download Created with Sketch. 499.69KB Share SPL Okamoto licenses VivaGel antiviral condom in Asian countries 04/03/20 PRICE SENSITIVE download Created with Sketch. 54.1KB Share SPL Interim Report and Half-Year Financial Results 24/02/20 PRICE SENSITIVE download Created with Sketch. 554.35KB Share SPL VivaGel BV launched in Asia 13/02/20 PRICE SENSITIVE download Created with Sketch. 50.93KB Share SPL Starpharma receives US$3M milestone from AstraZeneca 11/02/20 PRICE SENSITIVE download Created with Sketch. 50.6KB Share SPL Quarterly Cashflow Report 29/01/20 PRICE SENSITIVE download Created with Sketch. 93.11KB Share SPL Commencement of phase 1 trial for AZD0466 utilising DEP 30/12/19 PRICE SENSITIVE download Created with Sketch. 57.86KB Share SPL Starpharma receives $4.9M R&D tax incentive refund 16/12/19 PRICE SENSITIVE download Created with Sketch. 49.98KB Share SPL DEP cabazitaxel progresses to phase 2 on positive results 10/12/19 PRICE SENSITIVE download Created with Sketch. 305.2KB Share SPL AGM - Chairman address and CEO presentation 21/11/19 PRICE SENSITIVE download Created with Sketch. 3.35MB Share SPL VivaGel condom receives regulatory approval in Europe 20/11/19 PRICE SENSITIVE download Created with Sketch. 62.82KB Share SPL UK launch of VivaGel BV 13/11/19 PRICE SENSITIVE download Created with Sketch. 73.67KB Share SPL DEP outperforms Gemzar in human pancreatic cancer model 31/10/19 PRICE SENSITIVE download Created with Sketch. 104.09KB Share SPL Quarterly Cashflow Report 30/10/19 PRICE SENSITIVE download Created with Sketch. 178.02KB Share SPL FDA Authorises Clinical Trial with AstraZeneca DEP product 26/09/19 PRICE SENSITIVE download Created with Sketch. 64.77KB Share SPL DEP irinotecan synergistic with Lynparza in refractory model 12/09/19 PRICE SENSITIVE download Created with Sketch. 116.83KB Share SPL VivaGel BV regulatory approvals continue in Asia 03/09/19 PRICE SENSITIVE download Created with Sketch. 127.57KB Share SPL Positive results with Targeted DEP using antibody fragment 29/08/19 PRICE SENSITIVE download Created with Sketch. 100.01KB Share SPL Starpharma annual report and full year financial results 28/08/19 PRICE SENSITIVE download Created with Sketch. 4.37MB Share SPL Promising efficacy signals observed in ongoing DEP trials 28/08/19 PRICE SENSITIVE download Created with Sketch. 246.47KB Share SPL First Asian Regulatory Approvals Received for VivaGel BV 15/08/19 PRICE SENSITIVE download Created with Sketch. 61.81KB Share SPL Starpharma commences phase 1/2 DEP irinotecan trial 08/08/19 PRICE SENSITIVE download Created with Sketch. 133.55KB Share SPL Quarterly Cashflow Report 16/07/19 PRICE SENSITIVE download Created with Sketch. 210.9KB Share SPL VivaGel BV launched in Europe 27/06/19 PRICE SENSITIVE download Created with Sketch. 69.36KB Share SPL Starpharma signs second oncology agreement with AstraZeneca 03/06/19 PRICE SENSITIVE download Created with Sketch. 125.34KB Share SPL DEP irinotecan combination outperforms in colon cancel model 24/05/19 PRICE SENSITIVE download Created with Sketch. 213.21KB Share SPL Quarterly Cashflow Report 29/04/19 PRICE SENSITIVE download Created with Sketch. 172.39KB Share SPL First VivaGel BV launch globally in Australia by Aspen 16/04/19 PRICE SENSITIVE download Created with Sketch. 127.48KB Share SPL Starpharma receives $4.0M R&D tax incentive refund 12/03/19 PRICE SENSITIVE download Created with Sketch. 117.6KB Share SPL Interim Report and Half-Yearly Financial Results 27/02/19 PRICE SENSITIVE download Created with Sketch. 765.59KB Share SPL Quarterly Cashflow Report 30/01/19 PRICE SENSITIVE download Created with Sketch. 309.77KB Share SPL Response to ASX Aware Letter 07/01/19 PRICE SENSITIVE download Created with Sketch. 445.4KB Share SPL VivaGel condom receives final regulatory approval in Japan 02/01/19 PRICE SENSITIVE download Created with Sketch. 113.95KB Share SPL US FDA requests further data for VivaGel BV approval 27/12/18 PRICE SENSITIVE download Created with Sketch. 128.38KB Share SPL US VivaGel BV licensed for A$142M milestones plus royalties 20/12/18 PRICE SENSITIVE download Created with Sketch. 134.83KB Share SPL AGM - Chairman address and CEO presentation 29/11/18 PRICE SENSITIVE download Created with Sketch. 4.08MB Share SPL DEP products outperform in human pancreatic cancer model 16/11/18 PRICE SENSITIVE download Created with Sketch. 377.73KB Share SPL Quarterly Cashflow Report 26/10/18 PRICE SENSITIVE download Created with Sketch. 312.5KB Share SPL Starpharma Investor Presentation for Citi Conference 17/10/18 PRICE SENSITIVE download Created with Sketch. 2.9MB Share SPL DEP irinotecan outperforms in pancreatic cancer model 05/09/18 PRICE SENSITIVE download Created with Sketch. 154.02KB Share SPL AstraZeneca DEP Bcl2/xL inhibitors show compelling efficacy 31/08/18 PRICE SENSITIVE download Created with Sketch. 140.72KB Share SPL Annual report and full year financial results 21/08/18 PRICE SENSITIVE download Created with Sketch. 3.6MB Share SPL Quarterly Cashflow Report 17/07/18 PRICE SENSITIVE download Created with Sketch. 227.14KB Share SPL VivaGel BV NDA advances to next stage of FDA review 09/07/18 PRICE SENSITIVE download Created with Sketch. 119.38KB Share SPL Starpharma licenses VivaGel BV to Mundipharma for Europe 27/06/18 PRICE SENSITIVE download Created with Sketch. 141.64KB Share SPL Mundipharma licenses Starpharma's VivaGel BV 03/05/18 PRICE SENSITIVE download Created with Sketch. 153.35KB Share SPL Appendix 4C - Quarterly Cashflow Report 30/04/18 PRICE SENSITIVE download Created with Sketch. 239.17KB Share SPL Starpharma completes US New Drug Application for VivaGel BV 30/04/18 PRICE SENSITIVE download Created with Sketch. 147.44KB Share SPL Interim Report and Half-Yearly Financial Results 26/02/18 PRICE SENSITIVE download Created with Sketch. 467.21KB Share SPL Starpharma receives $3.7M R&D tax incentive refund 22/02/18 PRICE SENSITIVE download Created with Sketch. 125.51KB Share SPL Starpharma to commence DEP cabazitaxel phase 1/2 trial 31/01/18 PRICE SENSITIVE download Created with Sketch. 146.38KB Share SPL Appendix 4C - Quarterly Cashflow Report 25/01/18 PRICE SENSITIVE download Created with Sketch. 690.96KB Share SPL VivaGel BV treatment clinical submission under rolling NDA 21/12/17 PRICE SENSITIVE download Created with Sketch. 166.62KB Share SPL NDA submission for VivaGel BV in the US 21/11/17 PRICE SENSITIVE download Created with Sketch. 159.47KB Share SPL Appendix 4C - Quarterly Cashflow Report 26/10/17 PRICE SENSITIVE download Created with Sketch. 231.4KB Share SPL VivaGel BV granted marketing approval in Australia 25/10/17 PRICE SENSITIVE download Created with Sketch. 83.81KB Share SPL Starpharma and Peter Mac Cancer Centre awarded DEP Grant 09/10/17 PRICE SENSITIVE download Created with Sketch. 58.58KB Share SPL AstraZeneca presents 1st DEP candidate as Bcl2/xL inhibitor 28/09/17 PRICE SENSITIVE download Created with Sketch. 138.54KB Share SPL DEP docetaxel positive phase 1 results, phase 2 commences 22/09/17 PRICE SENSITIVE download Created with Sketch. 363.52KB Share SPL Annual report and full year financial results 28/08/17 PRICE SENSITIVE download Created with Sketch. 1.77MB Share SPL Starpharma and Monash awarded STEM Business Fellowships 09/08/17 PRICE SENSITIVE download Created with Sketch. 138.26KB Share SPL Successful VivaGel Phase 3 results and NDA planned for rBV 07/08/17 PRICE SENSITIVE download Created with Sketch. 424.4KB Share SPL Appendix 4C - Quarterly Cashflow Report 19/07/17 PRICE SENSITIVE download Created with Sketch. 169.14KB Share SPL VivaGel BV phase 3 results timing and commercialisation 04/07/17 PRICE SENSITIVE download Created with Sketch. 173.13KB Share SPL Starpharma sells Agrochemicals business to Agrium for $35M 14/06/17 PRICE SENSITIVE download Created with Sketch. 179.92KB Share SPL DEP irinotecan outperforms irinotecan in cancer models 06/06/17 PRICE SENSITIVE download Created with Sketch. 349.39KB Share SPL Appendix 4C - Quarterly Cashflow Report 28/04/17 PRICE SENSITIVE download Created with Sketch. 120.37KB Share SPL AstraZeneca DEP candidate advance triggers milestone to SPL 20/04/17 PRICE SENSITIVE download Created with Sketch. 91.82KB Share SPL Ansell launches VivaGel condom in Canada 12/04/17 PRICE SENSITIVE download Created with Sketch. 65.41KB Share SPL VivaGel BV phase 3 trials for prevention of BV completed 30/03/17 PRICE SENSITIVE download Created with Sketch. 338.32KB Share SPL Interim Report and Half-Year Financial Results 27/02/17 PRICE SENSITIVE download Created with Sketch. 628.3KB Share SPL Appendix 4C - Quarterly Cashflow Report 31/01/17 PRICE SENSITIVE download Created with Sketch. 119.52KB Share SPL Shareholder Update January 2017 19/01/17 PRICE SENSITIVE download Created with Sketch. 751.87KB Share SPL VivaGel BV granted QIDP and Fast Track designation by US FDA 12/01/17 PRICE SENSITIVE download Created with Sketch. 89.15KB Share SPL Starpharma receives $3.5M R&D tax incentive refund 22/12/16 PRICE SENSITIVE download Created with Sketch. 94.7KB Share SPL Starpharma signs license for VivaGel Condom in Iran 28/11/16 PRICE SENSITIVE download Created with Sketch. 95.11KB Share SPL Appendix 4C - Quarterly Cashflow Report-SPL.AX 28/10/16 PRICE SENSITIVE download Created with Sketch. 296.3KB Share SPL Additional Priostar Glyphosate Patent Allowed in US-SPL.AX 28/10/16 PRICE SENSITIVE download Created with Sketch. 175.55KB Share
(20min delay)
